September 22, 2008 - GE Healthcare demonstrated a new diagnostic tool for heart failure called SyncTool by Syntermed on its GE Xeleris 2 workstations at the American Society of Nuclear Cardiology, Sept. 10-14, in Boston.
SyncTool software is designed to help to predict which heart failure patients will benefit from cardiac resynchronization therapy (CRT). SyncTool uses multiharmonic phase analysis (MHPA), a technology developed by Emory University medical scientists Ernest Garcia, Ph.D., and Ji Chen, Ph.D., and was licensed exclusively to Syntermed by Emory in June 2008. The software provides an automated analysis of LV function of conventional ECG-gated SPECT myocardial perfusion imaging.
Emory University announced it is exclusively licensing Emory Reconstruction Toolbox (ERTb) to Syntermed and the company will market ERTb software as ReconTools. ReconTools provide reconstructed data sets that can be analyzed by many quantitative platforms including Emory Cardiac Toolbox (ECTb), providing an integrated, complete software solution for myocardial perfusion SPECT imaging.
GE Healthcare is licensing SyncTool software as part of an Emory Cardiac Toolbox (ECTb) upgrade on all Xeleris 2 workstations. This software helps to predict which heart failure patients will benefit from cardiac resynchronization therapy (CRT).
Emory University announced it is exclusively licensing Emory Reconstruction Toolbox (ERTb) to Syntermed. The company will market ERTb software as ReconTools.
For more information: www.syntermed.com
July 30, 2024 
